𝔖 Bobbio Scriptorium

✦ LIBER ✦

Pharmacokinetics and pharmacodynamics of AZD6244 (ARRY-142886) in tumor-bearing nude mice

✍ Scribed by Cathrine L. Denton; Daniel L. Gustafson

Book ID: 105993448
Publisher: Springer
Year: 2010
Tongue: English
Weight: 772 KB
Volume: 67
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-010-1323-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

342 Anti-tumor activity, pharmacokinetic

342 Anti-tumor activity, pharmacokinetic and pharmacodynamic effects of the MEK inhibitor ARRY-142886 (AZD6244) in a BxPC3 pancreatic tumor xenograft model

✍ J.D. Winkler; P.A. Lee; E. Wallace; G. Poch; K. Litwiler; T. Pheneger; J. Lyssik 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 281 KB

26 ORAL Phase Ib and pharmacodynamic stu

26 ORAL Phase Ib and pharmacodynamic study of the MEK inhibitor AZD6244 (ARRY-142886) in patients with advanced solid malignancies

✍ A. Adjei; R.B. Cohen; W.A. Franklin; J. Molina; S. Hariharan; E. Temmer; S. Brow 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 82 KB

368 Demonstration of broad in vivo anti-

368 Demonstration of broad in vivo anti-tumor activity of ARRY-142886 (AZD-6244), a potent and selective MEK inhibitor

✍ P.A. Lee; E. Wallace; T.C. Yeh; G. Poch; D. Hunt; T. Pheneger; R. Woessner; S. C 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Detection of BRAF mutations in the tumou

Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study

✍ Board, R E; Ellison, G; Orr, M C M; Kemsley, K R; McWalter, G; Blockley, L Y; De 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 334 KB

P030 An ERK-inhibitor AZD6244 (ARRY-1428

P030 An ERK-inhibitor AZD6244 (ARRY-142886) enhances the anti-tumor activitiy of sorafenib therapy in a xenograft model of human renal cell carcinoma (RCC)

✍ Yuen, J.; Sim, Y.; Huynh, H. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Phase II Efficacy and Pharmacogenomic St

Phase II Efficacy and Pharmacogenomic Study of Selumetinib (AZD6244; ARRY-142886) in Iodine-131 Refractory Papillary Thyroid Carcinoma with or without Follicular Elements

✍ Hayes, D. N.; Lucas, A. S.; Tanvetyanon, T.; Krzyzanowska, M. K.; Chung, C. H.; 📂 Article 📅 2012 🏛 American Association for Cancer Research 🌐 English ⚖ 427 KB